BlackRock Institutional Trust Company, N.A. - CANCER GENETICS INC ownership

CANCER GENETICS INC's ticker is CGIXXXXX and the CUSIP is 13739U104. A total of 30 filers reported holding CANCER GENETICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Institutional Trust Company, N.A. ownership history of CANCER GENETICS INC
ValueSharesWeighting
Q4 2016$17,000
-22.7%
12,4240.0%0.00%
Q3 2016$22,000
-12.0%
12,4240.0%0.00%
Q2 2016$25,000
-28.6%
12,4240.0%0.00%
Q1 2016$35,000
-14.6%
12,4240.0%0.00%
Q4 2015$41,000
-57.7%
12,4240.0%0.00%
Q3 2015$97,000
-33.6%
12,4240.0%0.00%
Q2 2015$146,000
+50.5%
12,4240.0%0.00%
Q1 2015$97,0000.0%12,424
-14.5%
0.00%
Q4 2014$97,000
-26.0%
14,5270.0%0.00%
Q3 2014$131,000
+87.1%
14,527
+135.7%
0.00%
Q2 2014$70,000
+366.7%
6,164
+534.8%
0.00%
Q1 2014$15,0009710.00%
Other shareholders
CANCER GENETICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
DOMINI IMPACT INVESTMENTS LLC 30,048$235,0003.84%
Millrace Asset Group, Inc. 198,774$1,554,0001.67%
EAM Investors, LLC 129,972$1,016,0000.16%
TURNER INVESTMENTS LLC 94,730$741,0000.15%
Granite Investment Partners, LLC 156,993$1,227,0000.12%
Sterneck Capital Management, LLC 20,030$157,0000.10%
DIKER MANAGEMENT LLC 28,815$225,0000.05%
ARDSLEY ADVISORY PARTNERS LP 15,000$117,0000.03%
VANGUARD GROUP INC 4,972,880$172,109,0000.01%
DENVER INVESTMENT ADVISORS LLC 14,141$111,0000.01%
View complete list of CANCER GENETICS INC shareholders